The effects of magnesium prophylaxis in migraine without aura

Magnesium Research

Volumn 21, Issue 2, 2008, Pages 101-108

  Köseoglu, Emel ^a   Talaslioglu, Abdullah ^a   Gönül, Ali Saffet ^b   Kula, Mustafa ^a  

^a ERCIYES UNIVERSITY   (Turkey)

^b EGE UNIVERSITY   (Turkey)

Author keywords

Magnesium; Migraine without aura; Prophylaxis

Indexed keywords

MAGNESIUM;

ADULT; ARTICLE; BRAIN; BRAIN CIRCULATION; BRAIN MAPPING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; EVOKED VISUAL RESPONSE; FEMALE; HUMAN; MALE; MIDDLE AGED; MIGRAINE WITHOUT AURA; ORAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; SCINTISCANNING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ADMINISTRATION, ORAL; ADULT; BRAIN; BRAIN MAPPING; CEREBROVASCULAR CIRCULATION; DOUBLE-BLIND METHOD; EVOKED POTENTIALS, VISUAL; FEMALE; HUMANS; MAGNESIUM; MALE; MIDDLE AGED; MIGRAINE WITHOUT AURA; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 48249127296     PISSN: 09531424     EISSN: None     Source Type: Journal    
DOI: 10.1684/mrh.2008.0132     Document Type: Article

References (32)

1. al-Ghamdi SM, Cameron EC, Sutton RA. Magnesium deficiency: pathophysiologic and clinical overview. Am J Kidney Dis 1994; 24: 737-52.
2. Gallai V, Sarchielli P, Morucci P, Abbritti G. Red blood cell magnesium levels in migraine patients. Cephalalgia 1993; 13: 94-8.
3. 2+ ratio. Headache 1993; 33: 135-8.
4. Sarchielli P, Coata G, Firenze C, Morucci P, Abbritti G, Gallai V. Serum and salivary magnesium levels migraine and tension- type headache. Results in a group of adult patients. Cephalalgia 1992; 12: 21-7.
5. Schoenen J, Sianard-Gainko J, Lenaerts M. Blood magnesium levels in migraine. Cephalalgia 1991; 11: 97-9.
6. Altura BT, Altura BM. Withdrawal of magnesium causes vasospasm while elevated magnesium produces relaxation of tone in cerebral arteries. Neurosci Lett 1980; 20: 323-7.
7. Nadler JL, Goodson S, Rude RK. Evidence that prostacyclin mediates the vascular action of magnesium in humans. Hypertension 1987; 9: 379-83.
8. Mody I, Lambert JD, Heinemann U. Low extracellular magnesium induces epileptiform activity and spreading depression in rat hippocampal slices. J Neurophysiol 1987; 57: 869-88.
9. Facchinetti F, Sances G, Borella P, Genazzani AR, Nappi G. Magnesium prophylaxis of menstrual migraine: effects on intracellular magnesium. Headache 1991; 31: 298-301.
10. Peikert A, Wilimzig C, Kohne-Volland R. Prophylaxis of migraine with oral magnesium: results from a prospective, multi-center, placebo-controlled and double-blind randomized study. Cephalalgia 1996; 16: 257-63.
11. Pfaffenrath V, Wessely P, Meyer C, Isler HR, Evers S, Grotemeyer KH, Taneri Z, Soyka D, Gobel H, Fischer M. Magnesium in the prophylaxis of migraine- a double blind placebo-controlled study. Cephalalgia 1996; 16: 436-40.
12. Wang F, Van Den Eeden SK, Ackerson LM, Salk SE, Reince RH, Elin RJ. Oral magnesium oxide prophylaxis of frequent migrainous headache in children: A randomized, double blind, placebo controlled trial. Headache 2003; 43: 601-10.
13. nd Edition. Cephalalgia 2004; 24(Suppl. 1): 23-136.
14. nd Edition. Cephalalgia 2004; 24(Suppl. 1): 137-49.
15. Friston KJ, Holmes AP, Worsley KJ, Poline JP, Frith CD, Frackowiak RSJ. Statistical parametric maps in functional imaging: A general linear approach. Hum Brain Mapp 1995; 2: 189-210.
16. Stamatakis EA, Glabus MF, Wyper DJ, Barnes A, Wilson JTL. Validation of statistical parametric mapping (SPM) in assessing cerebral lesions: a simulation study. Neuroimage 1999; 10: 397-407.
17. Talairach J, Tournoux P. Co-Planar Stereotactic Atlas of the Human Brain 3-Dimensional Proportional System: An Approach to Cerebral Imaging. New York: Thieme Medical, 1988.
18. Bigal M, Bordini C, Tepper S, Speciali J. Intravenous magnesium sulphate in the acute treatment of migraine without aura and migraine with aura. A randomized, double-blind, placebo-controlled study. Cephalalgia 2002; 22: 345-53.
19. Demirkaya S, Vural O, Dora B, Topcuoglu MA. Efficacy of intravenous magnesium sulfate in the treatment of acute migraine attacks. Headache 2001; 41: 171-7.
20. Mauskop A, Altura BT, Cracco RQ, Altura BM. Intravenous magnesium sulfate rapidly alleviates headaches of various types. Headache 1996; 36: 154-60.
21. Mauskop A. Editorial: Evidence linking magnesium deficiency to migraines. Cephalalgia 1999; 19: 766-7.
22. Taylor FR, Evans RW. Expert opinion: Natural or alternative medications for migraine prevention. Headache 2006; 46: 1012-8.
23. Spreafico C, Frigerio R, Santoro P, Ferrarese C, Agostoni E. Visual evoked potentials in migraine. Neurol Sci 2004; 25: S288-S290.
24. Aloisi P, Marelli A, Porto C, Tozzi E, Cerone G. Visual evoked potentials and serum magnesium levels in migraine patients. Headache 1997; 37: 383-5.
25. Diener HC, Scholz E, Dichgans J, Gerber WD, Jack A, Bille A, Niederberger U. Central effects of drugs used in migraine prophylaxis evaluated by visual evoked potentials. Ann Neurol 1989; 25: 125-30.
26. May A. The contribution of functional neuroimaging to primary headaches. Neurol Sci 2004; 25: S85-S88.
27. Mirza M, Tutus A, Erdogan F, Kula M, Tomar A, Silov G, Koseoglu E. Interictal SPECT with Tc-99m HMPAO studies in migraine patients. Acta Neurol Belg 1998; 98: 190-4.
28. Maini CL, Turco GL, Castellano G, Liboni W, Podio W, Chianale G, Cornaglia G. Cerebral blood flow and volume in symptom-free migraineurs: a SPECT study. Nuklearmedizin 1990; 29: 210-4.
29. Ramadan NM, Lewine SR, Welch KMA. Interictal cerebral blood flow aymmetries in migraine with aura. Cephalalgia 1991; 11(Suppl.): 42-3.
30. Ferrari MD, Haan J, Blokland JA, Arndt JW, Miance P, Zwinderman AH, Pauwels EK, Saxena PR. Cerebral blood flow during migraine attacks without aura and effect of sumatriptan. Arch Neurol 1995; 52: 135-9.
31. Olesen J, Lauritzen M, Tfelt Hansen P, Henriksen L, Larsen B. Spreading cerebral oligemia in classical- and normal cerebral blood flow in common migraine. Headache 1982; 22: 242-8.
32. 99mTc-HMPAO SPECT study. Cephalalgia 1992; 12: 284-8.